Search Funding Opportunities

Geneva provides comprehensive and tailored proposal development support to researchers engaged in federal grants and contracts. Our expertise within the federal research community ensures a competitive proposal submission.

The following list represents a selection of funding opportunities relevant to the military medical research community.

Sign up at the bottom of this page to receive a funding bulletin directly to your inbox. Or contact us directly if you need help identifying a funding opportunity.

Contact Us
Search
Title Opportunity Number Funding Agency Deadline
Peer Reviewed Orthopaedic Research Program (PRORP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Melanoma Research Program (MRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Prostate Cancer Research Program (PCRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Spinal Cord Injury Research Program (SCIRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Passive Data Collection using Autonomous Documentation (AutoDoc) Project – Development of Passive Sensor Suite MTEC-24-05 AutoDocSensor MTEC 3/1/2024
Simulation Ecosystem Development for Validation of Emerging Technologies within the Autonomous Casualty Care (AC2) Research Portfolio MTEC-24-06 Simulation MTEC 3/8/2024
Hearing Restoration Research Program (HRRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Joint Warfighter Medical Research Program (JWMRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Lung Cancer Research Program (LCRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Tuberous Sclerosis Research Program (TSCRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Autism Research Program (ARP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Vision Research Program (VRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Critical Path Public Private Partnerships RFA-FD-24-027 HHS-FDA 3/4/2024
Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional RFA-FD-24-029 HHS-FDA 3/4/2024
Amyotrophic Lateral Sclerosis Research Program (ALSRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Peer Reviewed Alzheimer's Research Program (PRARP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
U.S. Army Research Institute for the Behavioral and Social Sciences BAA for Basic Research (FY2025) W911NF24S0005 DOD-AMC 7/1/2024
Ovarian Cancer Research Program (OCRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Breast Cancer Research Program (BCRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Epilepsy Research Program (ERP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-24-019 NIH 1/8/2027
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR-24-036 NIH 11/3/2026
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR-24-035 NIH 11/3/2026
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease NOT-DE-23-007 NIH 5/10/2027
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives NOT-AI-23-076 NIH 7/17/2026
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed) PAS-24-058 NIH 5/8/2024
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed) PAS-24-057 NIH 5/8/2024
Broad Agency Announcement (BAA) for the Protection of Deployed Military Personnel From Threats Posed by Arthropod Disease Vectors AFPMB-BAA-24-01 DoD 10/19/2028
2024 Human Exploration Research Opportunities (HERO) Overview 80JSC024NA001 NASA Johnson Space Center 10/30/2024
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 HHS/BARDA-ASPR 10/10/2028
Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) NOT-NS-24-008 NIH (NINDS) Forecasted
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) RFA-EY-23-001 NIH 6/16/2026
Advanced Research Projects Agency for Health (ARPA-H) Open-Office Broad Agency Announcement (BAA) 75N99223S0001 ARPAH 3/14/2024
US Special Operations Command - Broad Agency Announcement for Extramural Biomedical Research and Development HT9425-23-S-SOC1 DOD-AMRAA 7/31/2028
United States Army Research Institute for the Behavioral And Social Sciences (ARI) BAA for Basic, Applied, And Advanced Scientific Research W911NF-23-S-0010 DOD-AMC 4/30/2028
Advanced Research Projects Agency for Health (ARPA-H) Open-Office Broad Agency Announcement (BAA) 75N99223S0001 HHS/ARPA-H 3/14/2024
Orthopaedic Research and Education Foundation (OREF) various OREF varies with award
AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research NOT-HS-23-003 AHRQ See Notice
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs) NOT-AI-23-013 NIH Expires January 08, 2026
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) PA-21-265 NIH expires May 27, 2025
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) PA-22-047 NIH expires October 31, 2026
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) PA-22-048 NIH expires October 31, 2026
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) PA-21-164 NIH expires July 18, 2024
Notice of Special Interest (NOSI): Complement in Fundamental Immunology NOT-AI-23-012 NIH expires January 08, 2026
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 NIH expires September 08, 2025
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional) RFA-NS-22-069 NIH expires March 12, 2024
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) PAR-23-047 NIH 1/8/2026
Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission NOT-AI-22-064 NIH 1/8/2026
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-22-242 NIH 9/8/2025
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 NIH 9/8/2025
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early Stage Development (UG3/UH3 Clinical Trial Not Allowed) PAR-22-209 NIH (NINDS, NEI, NIDA, NIEHS) 10/18/2024
DoD USAMRDC FY23-FY27 Broad Agency Announcement for Extramural Medical Research HT9425-23-S-BAA1 DOD-AMRAA 9/30/2027
Broad Agency Announcement Research and Development In Support of The Joint Program Executive Office For Chemical, Biological, Radiological And Nuclear Defense (JPEO-CBRND), JPM MEDICAL AND JPL EB W911SR-22-R-CBRN DOD 6/26/2027
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed) PAR-22-209 NIH 10/18/2024
Airman Readiness Medical Research (ARMR) Hybrid BAA FA8650-20-S-6008 DoD-AFRL 5/1/2025
Research Interests of the Air Force Office of Scientific Research FA9550-21-S-0001 DOD-AFOSR
US Army Combat Capabilities Development Command Broad Agency Announcement W911QY-20-R-0022 DOD-AMC-ACCAPGN 2/28/2025
Army Applications Lab Broad Agency Announcement for Disruptive Applications W911NF-19-S-0004 DOD-AMC 5/1/2024
BARDA DRIVe EZ-BAA BAA-20-100-SOL-0002 HHS - BARDA 7/6/2024
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine NOT-AI-22-013 NIH (NIAID) 1/8/2025
Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery NOT-AI-22-014 NIH (NIAID) 1/8/2025
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) PAR-22-127 NIH (NIGMS, NIA, NCI) 5/8/2025
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) PAR-22-126 NIH (NIGMS, NIA, NCI) 5/8/2025
Research Program Award (R35 Clinical Trial Optional) RFA-NS-22-038 NIH (NINDS) 7/16/2024
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) PAR-22-076 NIH (NINDS) 5/8/2025
Notice of Special Interest (NOSI): CCRP Administrative Supplement for Collaborative Science to Synergize Chemical Medical Countermeasures Discovery and Early Development NOT-AI-22-029 NIH (NIAID, NEI, NIAMS, NIDA, NIEHS, NINDS) 3/2/2024
Notice of Special Interest (NOSI): NIAID Administrative Supplement to Promote Discovery of Medical Countermeasures Against Chemical Threats NOT-AI-22-030 NIH (NIAID) 3/2/2024
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 NIH (NHLBI) 12/21/2024
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-23-010 NIH (NHLBI) 12/21/2024
Catalyze: Product Definition – Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-23-013 NIH (NHLBI) 12/21/2024
Catalyze: Product Definition – Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) RFA-HL-23-014 NIH (NHLBI) 12/22/2024
RFI: Neurotrauma Diagnosis, Monitoring, and Assessment State of Technology Meeting MTEC-23-11-Neurotrauma MTEC 9/14/2023

Get Funding Alerts Directly to Your Inbox